BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 27609832)

  • 1. Skeletal Muscle Alterations Are Exacerbated in Heart Failure With Reduced Compared With Preserved Ejection Fraction: Mediated by Circulating Cytokines?
    Seiler M; Bowen TS; Rolim N; Dieterlen MT; Werner S; Hoshi T; Fischer T; Mangner N; Linke A; Schuler G; Halle M; Wisloff U; Adams V
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27609832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle.
    Bowen TS; Rolim NP; Fischer T; Baekkerud FH; Medeiros A; Werner S; Brønstad E; Rognmo O; Mangner N; Linke A; Schuler G; Silva GJ; Wisløff U; Adams V;
    Eur J Heart Fail; 2015 Mar; 17(3):263-72. PubMed ID: 25655080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection Fraction.
    Bowen TS; Brauer D; Rolim NPL; Bækkerud FH; Kricke A; Ormbostad Berre AM; Fischer T; Linke A; da Silva GJ; Wisloff U; Adams V
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-proteasome-system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF.
    Adams V; Wunderlich S; Mangner N; Hommel J; Esefeld K; Gielen S; Halle M; Ellingsen Ø; Van Craenenbroeck EM; Wisløff U; Pieske B; Linke A; Winzer EB
    ESC Heart Fail; 2021 Aug; 8(4):2556-2568. PubMed ID: 33955206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle alterations in HFrEF vs. HFpEF.
    Adams V; Linke A; Winzer E
    Curr Heart Fail Rep; 2017 Dec; 14(6):489-497. PubMed ID: 28940089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction.
    Spiesshoefer J; Henke C; Kabitz HJ; Bengel P; Schütt K; Nofer JR; Spieker M; Orwat S; Diller GP; Strecker JK; Giannoni A; Dreher M; Randerath WJ; Boentert M; Tuleta I
    Respiration; 2021; 100(2):96-108. PubMed ID: 33171473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility.
    Adams V; Schauer A; Augstein A; Kirchhoff V; Draskowski R; Jannasch A; Goto K; Lyall G; Männel A; Barthel P; Mangner N; Winzer EB; Linke A; Labeit S
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1565-1581. PubMed ID: 35301823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction.
    Chaanine AH; Joyce LD; Stulak JM; Maltais S; Joyce DL; Dearani JA; Klaus K; Nair KS; Hajjar RJ; Redfield MM
    Circ Heart Fail; 2019 Feb; 12(2):e005131. PubMed ID: 30744415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal skeletal muscle blood flow, contractile mechanics and fibre morphology in a rat model of obese-HFpEF.
    Espino-Gonzalez E; Tickle PG; Benson AP; Kissane RWP; Askew GN; Egginton S; Bowen TS
    J Physiol; 2021 Feb; 599(3):981-1001. PubMed ID: 33347612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Endurance Training on Detrimental Structural, Cellular, and Functional Alterations in Skeletal Muscles of Heart Failure With Preserved Ejection Fraction.
    Bowen TS; Herz C; Rolim NPL; Berre AO; Halle M; Kricke A; Linke A; da Silva GJ; Wisloff U; Adams V
    J Card Fail; 2018 Sep; 24(9):603-613. PubMed ID: 30195827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
    Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
    Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology.
    Putko BN; Wang Z; Lo J; Anderson T; Becher H; Dyck JR; Kassiri Z; Oudit GY;
    PLoS One; 2014; 9(6):e99495. PubMed ID: 24923671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct features of calcium handling and β-adrenergic sensitivity in heart failure with preserved versus reduced ejection fraction.
    Kilfoil PJ; Lotteau S; Zhang R; Yue X; Aynaszyan S; Solymani RE; Cingolani E; Marbán E; Goldhaber JI
    J Physiol; 2020 Nov; 598(22):5091-5108. PubMed ID: 32829489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
    Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD;
    JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
    J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerobic Interval Training Elicits Different Hemodynamic Adaptations Between Heart Failure Patients with Preserved and Reduced Ejection Fraction.
    Fu TC; Yang NI; Wang CH; Cherng WJ; Chou SL; Pan TL; Wang JS
    Am J Phys Med Rehabil; 2016 Jan; 95(1):15-27. PubMed ID: 26053189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.